The European Commission (EC) has approved a single-vial, fully liquid presentation of Menveo (meningococcal Group A, C, W-135 ...

Kelun-Biotech has received marketing authorization in China for sacituzumab tirumotecan (sac-TMT), a Trop2-directed ADC for ...

AI-powered protein engineering company Cradle has raised $73 million in a Series B funding. The European firm, which has now ...

The Biden administration has proposed a new rule that could significantly expand Medicare and Medicaid coverage for obesity ...

US clinical stage biotech Alector saw its shares tumble 35% to $2.57 by close of trading yesterday, as it announced ...

Samsung Bioepis has appointed Kyung-Ah Kim as president and CEO, succeeding Christopher Hansung Ko. The leadership change ...

The US Food and Drug Administration (FDA) has extended the review period for Soleno Therapeutics’ the New Drug Application ...

PTC Therapeutics' Phase II trial for utreloxastat in ALS failed to meet its primary endpoint, showing no significant ...

Berlin, Germany-based Eckert & Ziegler Radiopharma has received approval of its proprietary non-carrier added Lutetium-177 ...

Japanese drugmaker Otsuka has announced the submission of a New Drug Application (NDA) to the Japanese Ministry of Health, ...

Novartis announced today that the European Commission (EC) has approved Kisqali (ribociclib) in combination with an aromatase inhibitor (AI) for the adjuvant treatment of patients with hormone ...

Swiss drugmaker Idorsia was trading more than 10% higher by lunchtime on Wednesday. Idorsia earlier announced that it has entered into exclusive negotiations with an undisclosed party for the global ...